Entrada Therapeutics Overview
Entrada Therapeutics Target Price
Analysts' 12-month price predictions for TRDA.
Get informed when a big investor buys or sells
+ FollowShare Price
$6.58
Average Target Price
$15.00
128% upside
128% upside2 analysts in the last 4 months
High: $20 | Low: $10
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-08 | Roth Capital | $10 | 52% upside |  |
| 2026-02-10 | Guggenheim | $20 | 204% upside | |
| 2026-01-28 | OppenheimerKostas Biliouris | $21 | 219.1% upside | |
| 2025-11-06 | Roth Capital | $13 | 97.6% upside | |
| 2025-02-28 | Roth Capital | $23 | 249.5% upside | |
| 2024-11-06 | H.C. WainwrightBoobalan Pachaiyappan | $20 | 204% upside | |
| 2024-06-25 | H.C. WainwrightRaghuram Selvaraju | $18 | 173.6% upside | |